-transparent.png){kind=logo}
The successful management of a patient with allergic asperillosis with triamcinolone acetonide for one year is reported. This patient had been maintained previously on systemic attempt to withdraw systemic corticosteroids continuously for eight years. An initial attempt to withdraw systemic steroids after initiation of aerosol therapy was unsuccessful; however, following bronchoscopic removal of mucus plugs, the transfer to maintenance therapy with triamcinolone aerosol alone was uneventful.
Related Publications
W W Pingleton, and
F C Hiller, and
R C Bone, and
G R Kerby, and
W E Ruth
December 1975,
Chest,
W W Pingleton, and
F C Hiller, and
R C Bone, and
G R Kerby, and
W E Ruth
May 1974,
The American review of respiratory disease,
W W Pingleton, and
F C Hiller, and
R C Bone, and
G R Kerby, and
W E Ruth
August 1978,
The Journal of allergy and clinical immunology,
W W Pingleton, and
F C Hiller, and
R C Bone, and
G R Kerby, and
W E Ruth
March 1977,
Annals of allergy,
W W Pingleton, and
F C Hiller, and
R C Bone, and
G R Kerby, and
W E Ruth
November 1976,
The Journal of the Kansas Medical Society,
W W Pingleton, and
F C Hiller, and
R C Bone, and
G R Kerby, and
W E Ruth
November 1991,
Annals of allergy,
W W Pingleton, and
F C Hiller, and
R C Bone, and
G R Kerby, and
W E Ruth
March 1997,
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
W W Pingleton, and
F C Hiller, and
R C Bone, and
G R Kerby, and
W E Ruth
January 1994,
Clinical therapeutics,
W W Pingleton, and
F C Hiller, and
R C Bone, and
G R Kerby, and
W E Ruth
February 1990,
Annals of allergy,
W W Pingleton, and
F C Hiller, and
R C Bone, and
G R Kerby, and
W E Ruth
November 1967,
Medical times,
